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Background: Evidence supports high prevalence of periodontitis in patients with chronic kidney disease. Several
renal factors have been proposed as possible modifiers of periodontitis pathogenesis in this population. In this cross
sectional study, we investigated whether distinct microbial profiles in renal patients could explain high periodontitis
prevalence.
Methods: We characterized the subgingival microbiome in 14 End Stage Renal Disease (ESRD) and 13 control
individuals with chronic periodontitis with similar demographic and clinical parameters. Medical, demographic
and periodontal parameters were recorded. Subgingival biofilm samples were collected from the deepest pocket
in two different quadrants and characterized via 454-pyrosequencing of the 16S rRNA gene.
Results: We found 874 species-level operational taxonomic units (OTU) across samples. Renal and control groups
did not differ in the individual proportions of periodontitis-associated taxa. However, in principal coordinate plots
of distance among samples based on OTU prevalence, some renal patients clustered apart from controls, with the
microbial communities of these outlier subjects showing less diversity. Univariate correlation analysis showed a
significant negative correlation between dialysis vintage and community diversity.
Conclusions: Within the study limitations, dialysis vintage was associated with a less diverse periodontal microbial
community in ESRD suggesting the need for further research.
Keywords: Periodontitis, Periodontal microbiome, Chronic kidney disease, 16S rRNA amplicon sequencing, Dialysis
vintage, End stage renal diseaseBackground
Chronic periodontitis, an infectious oral disease leading to
tooth loss, is highly prevalent in Chronic Kidney Disease
(CKD) with associations to malnutrition and inflammation
[1–4]. Although recent epidemiological evidence has
shown a periodontitis prevalence of 12.7 % in the general
population [5], it increased up to ~39 % in some racial
groups [6, 7] with a dose–response association in CKD
[8]. Smaller studies in End Stage Renal Disease (ESRD)
have reported a periodontitis prevalence of 29-64 %
[9, 10]. Several renal disease-related factors have been
hypothesized to contribute to the pathogenesis of
periodontitis in CKD, including uremia and related* Correspondence: Ioannidou@uchc.edu
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Uremic toxins may potentially alter the oral ecosystem
(hydrolysis of urea results in alkaline pH) promoting the
growth of periodontal pathogens, in a similar manner to
the demonstrated uremia-related changes in the gut envir-
onment [13, 14]. Studies using microbiological methods of
limited scope have shown that ESRD individuals with peri-
odontitis have increased levels of periodontal pathogens as
compared to non-CKD controls [15]. However, with the
recognition that chronic periodontitis is a complex infec-
tious disease associated with polymicrobial biofilms, more
emphasis is currently given to the study of subgingival
bacteria in the context of a community [16]. It is thus un-
known if the renal-related environmental effects of uremia
contribute to oral community dysbiosis. Hence, the goal of
this study was to compare the subgingival microbiomes of
ESRD and non-CKD control individuals with chronicticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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This cross-sectional pilot study included ESRD patients
on hemodialysis as well as control, non-CKD, individuals.
Patients with ESRD were recruited from the University of
Connecticut Dialysis Center in Farmington, CT and the
Springfield Dialysis Center in Springfield, MA. Control in-
dividuals were referred for periodontal treatment to the
Periodontology Graduate Clinic at the University of
Connecticut Health. All study procedures were ap-
proved by the Institutional Review Board of the Univer-
sity of Connecticut Health.
Participants were selected based on the following in-
clusion criteria: (1) at least one site with probing depth
(PD) of 5 mm or more and two or more interproximal
sites with clinical attachment loss (CAL) equal or more
than 6 mm [17], (2) a minimum of 15 teeth, (3) no his-
tory of smoking, (4) no history of antibiotic use within
the last month, and (5) no history of periodontal treat-
ment within the last year. ESRD patients requiring by
the nephrologist to take antibiotic prophylaxis prior to
dental treatment were not excluded from this study
since the single antibiotic dose was administered only
1 h prior to the sampling process and, therefore, did not
affect the sampling process.
Demographic and periodontal data collection
Study participants were informed about the study and
signed the approved informed consent. Once eligibility
for participation was established based on the inclusion/
exclusion criteria, demographic data were recorded and
medical history was reviewed. At this visit, participants
received a comprehensive oral examination, which in-
cluded number of missing teeth and plaque score (PS),
defined as percentage of surfaces positive for plaque;
pocket probing depths (PD), defined as the distance
from the gingival margin to the base of the pocket mea-
sured; bleeding on probing (BoP), defined as percentage
of surfaces positive for bleeding and clinical attachment
levels (CAL), defined as the distance from the cemento-
enamel junction to the base of the pocket measured. In
order to assess the extent of periodontitis, the percent-
age of sites with PD ≥5 mm was calculated.
Medical data
Medical history and biochemical data were extracted
from the patient medical record. More specifically, most
recent data on: 1) diabetes status, which was collected as
a categorical variable, 2) dialysis vintage, defined by the
number of dialysis years reflecting on ESRD chronicity[18], 3) serum albumin levels (g/dL), a biomarker of
malnutrition and inflammation [19], 4) Kt/V (where K =
dialyzer clearance of urea; t = dialysis time; and V = the
distribution volume of urea) reflecting on dialysis ad-
equacy and Blood Urea Nitrogen (BUN) (mg/dL), and 5)
antibiotic prophylaxis in a regimen of amoxicillin 2 g or
clindamycin 600 mg 1 h prior to the sampling visit.
Biofilm sampling
Subgingival plaque samples were collected from the dee-
pest pocket in two different quadrants after removal of
supragingival plaque. The two plaque samples from the
same individual were pooled and immediately placed in
a polypropylene tube containing 50 μl Tris-EDTA (TE)
buffer and stored at −80 °C.
DNA isolation, 16S rRNA gene library preparation and
sequencing
DNA was isolated from plaque samples using lysozyme
and proteinase K treatment and a DNeasy Blood and
Tissue kit (Qiagen) as previously described [20]. Positive
controls (a known bacterial culture) and negative control
samples for the assessment of sample contamination by
foreign DNA (lysis and TE buffers without any sample)
were also included.
Amplicon libraries of 16S rRNA gene V1-V2 hyper-
variable regions were generated in triplicate using fu-
sion primers, which included universal primers 8 F 5′
AGAGTTTGATCMTGGCTCAG3′ and 361R 5′CYIAC
TGCTGCCTCCCGTAG3′ [21], Roche Life Sciences’s
454 Lib-A adapters A and B and a unique multiplex
identifier. PCR and library preparation procedures have
been described previously [20]. Briefly, PCR reactions con-
tained 10 ng of purified DNA, 1 U platinum Taq polymer-
ase (Invitrogen), 1.5 mM MgCl2, 200 μM dNTPs, Taq
buffer (1x), 0.5 μM of each forward and reverse primer
and molecular grade water to a final volume of 25 μL.
Thermal cycler conditions were: initial denaturation at
95 °C for 3 min; 25 cycles of denaturation at 95 °C for
30 s, annealing at 50 °C for 30 s and extension at 72 °C for
1 min; and a final extension step at 72 °C for 9 min. A
negative PCR control with no added template was also in-
cluded at this step. Combined triplicate amplicon libraries
were sequenced in the forward direction using 454
Titanium chemistry on the 454-GS-FLX platform (454
Life Sciences). Sequences are available at the Short Reads
Archive (SRP number pending).
Sequence data processing
Sequence data were processed using a modification of
the pipeline of Schloss et al. [22], as previously described
[20], using mothur [23]. For Operational Taxonomic
Unit (OTU)-based analysis, sequences were clustered
using the average neighbor algorithm [24] and a 3 %
Table 1 Clinical and demographic characteristics of Control and
ESRD individuals
Characteristic Control (n = 13) ESRD (n = 14) p-value
Age (years)a 48.4 ± 10.6 60.1 ± 16.1 0.55
Gender (% male) (n)c 69.2 (9) 57.1 (8) 0.52
Ethnicity (% non-whites) (n)c 61.5 (8) 42.9 (6) 0.56
Diabetes status (% yes) (n)c 15.4 (2) 50.0 (7) 0.06
Full mouth PD (mm)b 3.15 (2.4-5.0) 2.84 (2.4-4.3) 0.07
Full mouth CAL (mm)b 3.40 (2.4-6.0) 3.13 (2.5-7.5) 0.33
BoP (% of sites)a 52.0 ± 25.0 37.0 ± 25.0 0.13
PS (% of sites)a 59.0 ± 20.0 74.0 ± 25.0 0.10
PD≥ 5 mm (% of sites)b 18.0 (4.0-65.0) 8.0 (3.0-45.0) 0.049
Sampled sites PD (mm)a 7.0 ± 0.8 6.3 ± 1.1 0.06
Sampled sites CAL (mm)a 7.6 ± 1.3 7.4 ± 2.1 0.74
Data represent mean ± standard deviation for normally distributed data,
median (interquartile range) for non-normally distributed data, or frequencies
(%) for dichotomous data
PD: pocket depth; CAL: clinical attachment level; BoP bleeding on probing; PS
plaque score; mm: millimeters
Statistical Tests: Independent t-test (a); Mann Whitney (b); Chi-square test (c)
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using the ribosomal database project (RDP) classifier
[25]. Template taxonomies included the RDP reference
dataset and the Human Oral Microbiome Database
(HOMD) [26]. OTUs were assigned a taxonomic identi-
fication based on the consensus assignment for the ma-
jority of sequences within each OTU. If a consensus
taxonomy was not possible at the species level (based on
HOMD), the nearest taxonomical rank at which a con-
sensus was reached was reported. In such cases, the rep-
resentative sequence from the OTU was also compared
to the HOMD and if results showed more than 97 %
similarity to an Oral Taxon (OT), the OT name of the
top hit was reported in parentheses as part of the OTU
taxonomy. Individually classified sequences were also
grouped into phylotypes (from genus to phylum level)
based on taxonomic identity.
Sequence libraries were sub-sampled to contain the
same number of sequences to facilitate comparisons.
Richness was evaluated by the number of observed
OTUs and also by the number of estimated OTUs, as
calculated with CatchAll [27], within a sample. Alpha-
diversity was measured by the non-parametric Shannon
index [28] and the inverse of the Simpson index [29]. β-
diversity, which is a measure of differences among sam-
ple libraries, was determined with the Jaccard Index for
comparison of communities based on membership (taxa
prevalence) and the θYC distance [30] for comparison of
communities according to their structure (taxa presence
and relative proportions). Principal Coordinate Analysis
(PCoA) of the distance among communities based on
the Jaccard and θYC metrics was performed in mothur
and graphs visualized using the rgl application within R
(http://www.r-project.org/). Methods used for DNA iso-
lation, amplicon library preparation, sequencing and
microbial profile analysis have been previously validated
using a mock community of oral microorganisms [20].
Statistical analyses
Clinical and demographic data were compared via t-test,
chi-square or Mann–Whitney tests for parametric and
non-parametric data, as appropriate. Differences in α-
diversity were evaluated by t-tests. Significant separation
of clusters after PCoA was evaluated via Analysis of
Molecular Variance (AMOVA) [31], as implemented in
mothur. Differences in relative abundances of individual
taxa were determined via LefSe [32], while differences
in taxon prevalence were tested via chi-square. The false
discovery rate method was used to adjust for multiple
comparisons. To facilitate interpretation of prevalence
data, we used the Chernoff bound to calculate the min-
imal relative abundance for which we could have 95 %
certainty that we will observe at least one sequence at
our sequencing effort [33]. Further, in CKD individuals,univariate Spearman’s correlation coefficient analysis
was performed to assess the association between micro-
biome diversity and CKD-related variables with P-
values < 0.05 considered to be statistically significant.
Results
Clinical and demographic descriptive analysis
Out of 52 ESRD and 17 control individuals, who gave
consent to the study, 14 and 13 fulfilled the eligibility
criteria, respectively. Among the 38 ESRD enrolled indi-
viduals, who failed the eligibility criteria, 6 patients were
smokers, 14 patients had less than 15 teeth, 10 patients
were periodontally healthy and 2 patients were on anti-
biotics for vascular access infections. In addition, four
participants in the control group failed the eligibility cri-
teria due to smoking. Table 1 shows the demographic
and clinical characteristics of control and ESRD partici-
pants. Age, gender, ethnicity, diabetes status and PD,
CAL, BoP and PS did not differ between groups. A mar-
ginal difference was found in the percentage of sites with
PD ≥ 5 mm (p = 0.049), indicating greater periodontitis
extent in the control group. The CAL and PD of sites
sampled for microbiological analyses, however, were not
different between groups (p = 0.74 and p = 0.06, respect-
ively). Hence, the two groups were considered periodon-
tally similar to test the research hypothesis.
Between group analysis of the subgingival microbiome
454-sequencing of 16S rRNA amplicon libraries from all
individuals yielded 207,368 sequences after trimming
and initial processing of sequence datasets. The range of
sequences per library was 4,666-25,340. Libraries were
normalized by random subsampling to contain the same
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found a total of 874 species-level (97 % similarity cutoff )
OTUs among these normalized libraries, a number in
agreement with recent taxonomic surveys of the subgin-
gival microbiome.
First, we evaluated whether renal status influenced α-
diversity, which is the diversity within a sample. The
number of OTUs present per library in controls was
175.3 ± 45.4 as opposed to 147.1 ± 56.0 in the ESRD
group. The inverse Simpson diversity index was 14.9 ±
8.1 in controls and 14.6 ± 11.0 in the ESRD group, while
the non-parametric Shannon index measured 3.4 ± 0.6 in
controls and 3.2 ± 1.0 in the ESRD group. None of these
values were significantly different between groups.Fig. 1 a: Difference in β-diversity in ESRD and Control samples. The plot w
according to community structure. b: β-diversity comparisons (arrows indic
which measures distance among samples according to taxa prevalence. c:
relative proportion in ESRD (red bards) and Control groups (green bars). DiControl and ESRD samples were then compared by
PCoA analysis to evaluate the renal status effect on the
global-scale composition of subgingival communities.
Figure 1a shows a PCoA plot based on the θYC index,
which measures distances among samples taking into ac-
count the presence and relative proportions of OTUs
within communities. ESRD and control groups did not
form discrete groups in this plot. However, when the
distance among samples was calculated using the Jaccard
index, which measures sample similarity based only on
OTU prevalence, a significant difference was found
(AMOVA = 0.023). Figure 1b shows the two data clouds
in the Jaccard-based PCoA plot. As seen in this Figure,
some ESRD samples clustered with the control group,as based on the θYC index, which measures distance among samples
ate the ESRD-O samples). The plot was based on the Jaccard Index,
Relative abundance of individual taxa. Individual OTUs with different
fferences in relative abundances were determined with LEfSe
Table 2 Comparison of clinical, demographic, alpha diversity,







Age (years)a 64.3 ± 13.4 55.8 ± 18.7 0.07
Gender (% male) (n)c 83.0 (5) 37.5 (3) <0.001
Ethnicity (% non-whites) (n)c 67.0 (4) 25.0 (2) <0.001
Periodontal data
PD (mm)§ 3.0 ± 0.7 3.0 ± 0.5 0.50
CAL (mm)a 3.6 ± 1.0 3.8 ± 1.7 0.35
BoP (% of sites)a 40.0 ± 28.0 29.0 ± 20.0 0.40
PS (% of sites)a 73.0 ± 28.0 72.0 ± 28.0 0.89
PD≥ 5 mm (% of sites)b 12.0 (5.0-45.0) 6.0 (3.0-36.0) 0.37
Alpha diversity
Number of observed OTUsa 101.8 ± 40.7 181.8 ± 39.0 0.004
Estimated OTUsa 169.0 ± 93.6 287.1 ± 68.3 0.029
Inverse simpson indexa 8.1 ± 5.8 19.5 ± 11.7 0.036
NP-Shannon Indexa 2.5 ± 1.2 3.7 ± 0.5 0.049
Shannon evennessa 0.5 ± 0.2 0.7 ± 0.1 1.00
CKD-related variables
Dialysis vintage (years)b 2.0 (1.25-4.0) 1 (1.0-5.0) 0.78
Antibiotic prophylaxis (% yes) (n)c 67.0 (4) 25.0 (2) 0.28
Albumin levels (g/dL)b 4.3 (3.7-4.4) 4.0 (3.0-4.3) 0.07
Diabetes status (% yes) (n)c 50.0 (3) 50.0 (4) 1.00
Dialysis adequacy (kt/V) b 1.56 ± 0.18 1.85 ± 0.46 0.67
BUN (mg/dL)a 59.33 ± 13.04 55.05 ± 18.26 0.36
Data represent mean ± standard deviation for normally distributed data,
median (interquartile range) for non-normally distributed data, or frequencies
(%) for dichotomous data
PD pocket depth; CAL clinical attachment level; BoP bleeding on probing; PS:
plaque score; mm millimeters; OTUs: Operational Taxonomic Units; g/dL: grams
per deciliter; mg/dL: milligrams per deciliter
Statistical Tests: Independent t-test (a); Mann Whitney (b); Chi-square test (c)
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Fig. 1b). Analysis of sample clustering based on phylogen-
etic distance metrics yielded similar results (weighed
UNIFRAC p > 0.05 and unweighted UNIFRAC p = 0.022).
Therefore, these analyses indicated that renal status was
not associated with a different subgingival community
structure but could influence the composition of commu-
nities. It should nevertheless be noted that prevalence
measures are dependent on depth of sampling. At the
current sampling effort (4,666 sequences), an OTU should
be present at a minimal relative abundance of 0.0017 % in
order to have 95 % certainty that we will observe at least
one sequence for this OTU [33].
Differences in the relative proportions and prevalence of
individual OTUs between control and ESRD individuals
were also evaluated. Figure 1c shows individual OTUs
with a significantly different relative proportion between
groups. This analysis indicates that only a small number
of OTUs differed between groups, with most of these
OTUs appearing as over-represented in the control
group. Moreover, no differences in the prevalence of in-
dividual OTUs between groups were found (data not
shown). These results suggested that renal status does
not appear to be related to a specific subgingival micro-
bial profile.
Within-group analysis of the subgingival microbiome in
CKD individuals
The heterogeneity observed in the ESRD group in terms
of community composition (Fig. 1b) was further investi-
gated by comparing the clinical and demographic par-
ticipant characteristics in the two ESRD subgroups: a)
ESRD-Control (ESRD-C) for their similarity with control
group, and b) ESRD-outliers (ESRD-O) indicated by an
arrow in Fig. 1b.
In a demographic comparison, the ESRD-O group was
older (p = 0.07) with more males (p < 0.001) and more
non-whites (p < 0.001) (Table 2) than the ESRD-C. The
ESRD groups showed no differences in Kt/V and BUN
(Table 1) reflecting dialysis adequacy. In terms of other
medical confounders, the subgroups were similar in
terms of diabetes status. When ESRD subgroups were
compared in terms of dialysis vintage (p = 0.92) and al-
bumin levels (p = 0.07), no statistically significant differ-
ences were found (Table 2). The subgroups were also
compared in terms of antibiotic prophylaxis frequency,
which could serve as an indicator of antibiotic exposure.
We found that 67 % of the ESRD-O received prophylactic
antibiotics in comparison to only 25 % in the ESRD-C
group. This difference, however, did not reach a statisti-
cally significant level (p = 0.28).
Periodontal clinical parameters (mean PD, mean CAL,
BoP, PS, and percentage of sites with PD ≥ 5 mm) did not
show statistical differences in the ESRD subgroup analysis.However, comparisons of the subgingival microbiomes
between ESRD subgroups showed that ESRD-O had de-
creased α-diversity compared to ESRD-C (Table 2), as well
as compared to all control samples (data not shown).
Therefore, the subgroups observed in Fig. 1b are likely to
be due to a decreased prevalence of certain taxa in the
ESRD-O. No specific taxa, however, could explain these
differences when taxa prevalence between ESRD-C and
ESRD-O were compared. This result was expected be-
cause of the broad separation among ESRD-O samples in
PCoA plots, indicating they were all different from each
other. Importantly, univariate Spearman’s correlation
analysis in both groups revealed a statistically significant
negative correlation between dialysis vintage and com-
munity diversity as measured by non-parametric Shannon
index (r2 = −0.58, p = 0.04) and the inverse of the Simpson
index (r2 = −0.71, p = 0.01) as well as community
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(r2 = −0.67, p = 0.02).
Discussion
In an effort to understand the high prevalence of peri-
odontitis in CKD, this pilot study examined the impact
of ESRD on the periodontal microbiome using global
microbial techniques. If we apply the polymicrobial syn-
ergy and dysbiosis model of periodontitis etiology [34]
to the ESRD population, uremia may be the missing link
perhaps causing the shift from microbial symbiosis to
dysbiosis in the subgingival ecosystem. The “disrupted
homeostatis” may trigger complicated host-microbial
interactions [34], already compromised by functional ab-
normalities of neutrophils, monocytes/macrophages and
dendritic cells [35–38] as well as impaired maturation of
T helper cells [39].
The present pilot study observed no major differences
in the subgingival microbiome between ESRD and control
individuals, apart from decreased α-diversity in some
ESRD individuals. Further, a small proportion of taxa with
increased relative abundance were observed in the control
group, including some periodontitis associated species
such as Prevotella intermedia and Filifactor alocis
(possibly explained by marginally higher periodontitis
extent in the control group).
When groups were compared based on β-diversity
metrics, composition disparities were identified between
ESRD and control individuals confirming some hetero-
geneity and decreased diversity within the ESRD sam-
ples. Our findings are in agreement with investigations
on the gut microbiome shown impressively similar clus-
tering patterns with some ESRD individuals clustering
tighter to the controls while others cluster apart [13].
Within the ESRD group, a significant negative correl-
ation was found between dialysis vintage and microbial
diversity and evenness indicating that the more the years
on dialysis, not only the less the diverse but also the less
even the microbial community was.
The human renal disease model is confounded by
multiple factors including underlying diseases and thera-
peutic interventions. Among the therapeutic interven-
tions, the dose, duration and frequency of antibiotic
intake documented in intestinal communities could re-
sult in microbial shifts [40]. Assuming that our data on
prophylactic antibiotics may reflect a pattern of frequent
antibiotic administration, the decreased community di-
versity in some ESRD individuals could be explained and
also confirmed by the inverse correlation of community
diversity/evenness and dialysis vintage.
There has been limited evidence on the subgingival
bacterial flora in CKD individuals using polymerase
chain reaction (PCR) techniques with conflicting re-
sults and methodological bias [41] [15]. Although thepresent cross sectional design prevented any tempor-
ality assessment, the contemporary microbial methods
strengthened the findings. Furthermore, this was a
pilot study with small sample size, which limited result
interpretation but validated our protocol hypothesis and
supported feasibility. Although we have recognized the
possible role of systemic antibiotics on microbial com-
munities, data on antibiotic frequency and dose since
dialysis initiation were not consistently available for this
analysis.
Findings from this study showed that ESRD patients
were adequately dialyzed as confirmed by the Kt/V mea-
sures. Therefore, in order to more accurately capture
“the elephant of uremia” [42] and its “stamps” on the
subgingival microbiome, our current conceptual model
could be tested in advanced CKD stages prior to renal
replacement therapy in a human CKD model for the
etiopathogenesis of periodontitis in renal disease with
controlled confounders such as chronic antibiotic usage.
Future research in a larger population may be needed to
examine the complete profile of these individuals at the
level of the dysbiotic microbial community as well as the
host response.
Conclusions
Within the limitations of this pilot study, we did not find
major differences in the subgingival microbiome be-
tween ESRD and control individuals, apart from de-
creased α-diversity in some ESRD individuals. However,
the results showed a significant negative correlation be-
tween dialysis vintage and microbial diversity and even-
ness. This finding indicated that the more the years on
dialysis, not only the less the diverse but also the less
even the microbial community was.
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